Clinical Trials Claeys SRL

Clinical Trials Claeys reported total assets of 872,473 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).

By total assets for 2025, Clinical Trials Claeys ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0863.913.573 · VAT BE0863913573
3052 Oud-Heverlee
active in Research and experimental development on other natural sciences and engineering (NACE 72109)
operating since 09 Mar 2004 (≈ 22 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Clinical Trials Claeys shows with a free account.

See the score
Profile
SRL since 2004
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result175,643 €
Equity757,494 €
Cash237,675 €
EBITDA246,678 €
Total assets872,473 €
The line marks its sector median: 60.4% (425 companies).

Change 2022 → 2025: Equity +56 % Total assets +70 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Clinical Trials Claeys's annual accounts

20252024202320222021
Net result175,643 €
Equity757,494 €
Cash237,675 €
EBITDA246,678 €
Total assets872,473 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 25 Aug 2026
  • Year ended 31 Dec 2024filed on 30 Jun 2025
  • Year ended 31 Dec 2023filed on 20 Jun 2024
  • Year ended 31 Dec 2022filed on 05 Jul 2023
  • Year ended 31 Dec 2021filed on 21 Jul 2022

Clinical Trials Claeys's financial analysis

Management and control of Clinical Trials Claeys

1 active director(s) in the register.

Clinical Trials Claeys's shareholders and holdings →

Clinical Trials Claeys's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0863.913.573
VAT number
BE0863913573
Peppol
Registered · 0208:0863913573 · as of 10 Nov 2026
Legal form
SRL
Incorporated
09 Mar 2004
Registered office
3052 Oud-Heverlee
Latest accounts
2025 · filed on 25 Aug 2026
Activity
Research and experimental development on other natural sciences and engineering (NACE 72109)

Clinical Trials Claeys (SRL) has been based in Oud-Heverlee since 2004, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 175,643 € and equity of 757,494 €; its revenue is not published. Its solvency stands at 86.8%, above the median of its sector (60.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Clinical Trials Claeys

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Clinical Trials Claeys

What is the revenue of Clinical Trials Claeys?

Clinical Trials Claeys files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Clinical Trials Claeys?

In Belgium, the VAT number is the company number prefixed with BE: BE0863913573 for Clinical Trials Claeys, if the company is VAT-registered. Its company number (CBE) is 0863.913.573.

Where is the registered office of Clinical Trials Claeys?

According to the CBE register, the registered office of Clinical Trials Claeys is in 3052 Oud-Heverlee.

What is the equity of Clinical Trials Claeys?

At the close of the 2025 financial year, the equity of Clinical Trials Claeys amounts to 757,494 €, a solvency of 86.8% of total assets.

Who manages Clinical Trials Claeys?

The register lists 1 active mandates at Clinical Trials Claeys. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Clinical Trials Claeys within its sector?

By total assets for 2025, Clinical Trials Claeys ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.

Idonis

The full file of Clinical Trials Claeys

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 01 Sep 2026

No credit card, no commitment.

What each plan unlocks →